Best Life Sciences Software

Benchling is a cloud platform for biotech R&D, and its current positioning has shifted decisively toward AI: "The AI Scientist connects predictive models, structured data, and wet lab execution into a single loop." It designs experiments, routes lab automation or guides manual execution, captures results as structured data, and recommends the next step, so each experiment is meant to compound on the last rather than sit as an isolated record.

Beneath that AI layer sits the collaborative, cloud-based notebook Benchling is originally known for, letting teams plan, record and share experiments, with automated workflows and analytics cutting manual and repetitive work , inventory management is one part of that broader digitised lab rather than a standalone feature. Benchling is aimed at biotech organisations with real R&D scale rather than a single academic lab.

MasterControl is an enterprise quality management system built for regulated life sciences companies, including pharmaceutical, biotech, and medical device manufacturers. It brings document control, training management, audit management, change control, CAPA, and risk management into one connected platform, with a no-code workflow designer and rules-based routing for building custom quality processes.

The platform adds AI-powered event summaries, deviation trend identification, and a patented Validation on Demand feature that speeds up software validation. MasterControl does not publish pricing online; it uses named-user licensing and requires contacting sales for a custom quote based on company size and selected modules, with published estimates commonly starting in the tens of thousands of dollars per year.

Schrödinger builds a physics-based software platform for molecular discovery and design, and the physics-based description is the substance of its position rather than marketing language. Where much of this field now leans on statistical prediction from prior data, Schrödinger's tools compute molecular behaviour from physical principles, which is what allows them to make useful predictions about molecules that resemble nothing in an existing dataset. The platform serves two distinct markets from a shared foundation: life science and materials science.

On the life science side, Maestro is the modelling environment, Glide handles ligand docking, FEP+ performs free energy perturbation calculations for binding affinity prediction, BioLuminate covers biologics, and LiveDesign is the collaborative design platform where teams work on candidates together. The solutions mapped to these run across the discovery pipeline: structure prediction, target enablement, hit discovery, hit-to-lead, lead optimisation and drug formulation. Beyond small molecules it covers mixed modalities including antibody design, peptide discovery, enzyme engineering, bifunctional degraders and TCR modelling.

Materials science uses the same physics with different products. MS Maestro is the modelling interface, Desmond runs molecular dynamics, and Jaguar performs quantum chemistry calculations. Applications include polymeric materials, organic electronics, energy capture and storage, thin film processing, catalysis and reactivity, consumer packaged goods, metals, alloys and ceramics, and pharmaceutical formulations and delivery. Industries served span aerospace, automotive, oil and gas, semiconductors and specialty chemicals as well as pharma and biotech. Modelling services and collaborations are available where teams lack in-house computational chemistry capacity, and the company publishes online certification courses, teaching curricula, tutorials and a Python API. Pricing is not published.

Veeva Vault is the platform layer beneath Veeva Systems' life sciences applications rather than a single application in its own right. That is the important distinction when evaluating it: organisations do not usually buy Vault alone, they buy Veeva applications that all run on Vault and therefore share one content and data model. The practical consequence is that a document produced in clinical work is the same object regulatory affairs references later, instead of a copy moved between systems, which is where version control and inspection readiness normally fail.

The application families built on it map to the regulated functions of a life sciences organisation. Clinical covers eTMF for inspection readiness, CTMS for end-to-end trial management, Study Startup for site activation, RTSM for randomisation and supply, Site Connect for information sharing with sites, Study Training, Payments for paying research sites, and Disclosures. Clinical data adds EDC for site data collection, DQS for aggregating and cleaning study data, and eCOA for patient-reported data. Regulatory runs through RIM, covering Registrations for global tracking, Submissions planning, Submissions Publishing to health authorities, and an archive of submission history.

Quality Cloud covers QMS, QualityDocs for GxP document control, Validation Management for paperless validation, Batch Release, Product Surveillance for postmarket medical device monitoring, and LIMS for quality control labs, with Training and accredited LearnGxP eLearning attached. The Safety Suite handles adverse event management, safety content, reporting and signal detection, and a Medical Suite covers publications and medical communications. Veeva serves life sciences, MedTech, consumer packaged goods, food and beverage, and chemical industries, with a Connections Hub for integrations. Pricing is not published.

Sapio Sciences sells a single configurable platform covering laboratory informatics, and describes it as the industry's first Science-aware agentic AI lab platform. The three products on it are Sapio LIMS, a no-code laboratory information management system with configurable workflows built for scientists rather than administrators, Sapio ELN, an AI-native electronic lab notebook designed to flex to the shape of each experiment, and the Sapio Scientific Data Cloud, a scientific data management system that unifies data and makes it accessible. The vendor's summary of the intent is that the platform should advance science rather than merely record it.

The no-code emphasis matters commercially. LIMS deployments usually fail on configuration cost, where each workflow change becomes a vendor engagement. Building for scientist-led configuration is a direct answer to that, though it is worth testing against your own most awkward workflow during evaluation. Elain, the AI co-scientist, is presented as a research partner, and the Elain Ecosystem makes scientific tools accessible through a single prompt rather than through separate interfaces.

Coverage is unusually wide for one platform. Research and development spans biotech R&D, chemistry R&D for small molecule discovery, next generation sequencing, multimodal discovery on a unified registry, bioprocessing upstream and downstream, in vivo testing and antibody discovery. Clinical diagnostics covers molecular diagnostics from physician request through to report, end-to-end NGS diagnostics and a physician ordering portal. Manufacturing covers GMP LIMS, QC LIMS for lot release, electronic batch records, stability monitoring, environmental monitoring and GMP compliance. Lab operations add sample and inventory management, flow cytometry gating, histopathology, bioanalysis, immunogenicity and biorepository management, with GxP, GLP and GCP validation. The interface is available in English, French, German, Italian, Japanese and Spanish. Pricing is not published.

L7 Informatics positions L7|ESP as an execution layer and operating system for regulated life sciences rather than as another point application. The distinction is deliberate: most labs run a LIMS, an electronic lab notebook, a manufacturing execution system and a scheduling tool from different vendors, then spend years integrating them. L7|ESP supplies all four as apps on one platform, so the process definition and the data model are shared instead of stitched together after purchase.

The platform components each handle a layer of that. L7|HUB, L7|INTELLIGENCE, L7|MASTER, L7|SYNAPSE and L7|EXCHANGE cover data hosting, analytics, master data, connectivity and exchange between systems. On top sit the business apps: L7 LIMS, L7 MES, L7 Notebooks and L7 Scheduling, alongside a set of standard apps. Rather than leaving customers to assemble these, L7 sells app packages built for defined operating contexts, including research, process and analytical development, manufacturing with QC and QA, clinical diagnostics, cell therapy and CMC work.

The industries addressed are specific enough to judge fit against. Pharmaceutical work covers small molecule medicine and advanced therapeutics, biotech covers advanced therapeutics, diagnostics covers molecular and companion diagnostics, and CDMOs are addressed for small and large molecule medicine. Academic research, cancer centres and cell and gene therapy labs, biomedical research institutions, contract research organisations running clinical trials, agricultural biotechnology working on new seeds and plant breeds, and life science tools vendors are all named. Ontology is a stated foundation for connected decision-making and AI-readiness. Services span operations assessment, data and process architecture, implementation, compliance support, build and maintain, and hosting, with L7 University providing skill paths, a course catalogue and live masterclasses. Pricing is not published.

Dotmatics addresses a specific structural problem in research and development: scientists use excellent specialist applications that do not share data, so results end up isolated by tool. Its Scientific Intelligence Platform is an AI-powered data management and workflow automation layer for multimodal scientific discovery, and the Luma product line exists to connect the company's own well-known desktop applications into it. The result is that a flow cytometry analysis, a sequence analysis and a chemistry record can sit in one traceable data model instead of three.

The Luma integrations show how this works in practice. Geneious Luma brings antibody discovery, sequence analysis and construct design from Geneious Prime and Geneious Biologics into adaptive workflows. FCS Express Luma and OMIQ Luma connect flow cytometry capture and cloud-native analysis to centralised data management with automated capture. BioGlyph Luma handles protein design for complex biologics, integrating molecular modelling, registration and production with data traceability. Lab Connect ingests instrument data automatically, structuring it as it arrives rather than after the fact.

The platform capabilities behind these are adaptive workflows for customising, automating and scaling lab processes, artificial intelligence and machine learning for predicting scientific outcomes, and material ontology management for classifying materials and managing entities with full traceability. The underlying product portfolio is broad and recognisable: SnapGene, Geneious Prime and Geneious Biologics for bioinformatics, Vortex for cheminformatics, Prism for data analysis and visualisation, an electronic lab notebook, OMIQ and FCS Express for flow cytometry, and Protein Metrics for proteomics. Named solutions cover antibody and protein engineering and flow cytometry, across biology discovery, chemistry R&D, and chemicals and materials. Pricing is not published, and on-demand demos are available.

BIOVIA is Dassault Systemes' scientific research and development portfolio, spanning biological, chemical and material industries rather than pharmaceuticals alone. That breadth is its defining characteristic: the same modelling and informatics foundation serves drug discovery, materials science and formulation work, which suits organisations whose research crosses those boundaries. The vendor states thousands of companies use it, and positions the goal as redefining the speed of research and development.

The current emphasis is generative AI applied to science. BIOVIA Scientific AI is described as giving every scientist generative technology to design faster, experiment virtually and create more successful products through AI-powered Virtual Twins, the digital counterparts of physical experiments that let candidates be assessed before laboratory work begins. A partnership with NVIDIA combines accelerated AI inference with the vendor's scientific modelling, aimed at next-generation therapeutics and high-performance materials. MARIE is an AI virtual companion within the portfolio.

The named products cover distinct research jobs. Discovery Studio and Materials Studio handle simulation for biological and materials work respectively. Generative Therapeutics Design targets novel therapy candidates. Pipeline Pilot is the scientific workflow and data pipelining tool. ONE Lab covers laboratory operations. Disciplines addressed include biosciences, laboratory informatics, materials science engineering, regulatory management, scientific informatics and quality management, with the AI-Ready Lab theme focused on producing high-quality, AI-ready data from the point of capture using a unified data model. Everything runs on the open, collaborative 3DEXPERIENCE platform. Contract research services and training are offered alongside the software, and industry solutions extend to consumer packaged goods, retail, infrastructure, energy and transportation. Pricing is not published.

Certara sells drug development software organised by development phase rather than by technical function, which makes it unusually easy to place against a pipeline. Its solutions run from discovery through preclinical, early clinical and late clinical to market access and commercial, with regulatory strategy running alongside. The vendor combines science, technology, and strategic and regulatory expertise, so software is sold with consulting rather than as a standalone licence.

Model-Informed Drug Development is the intellectual core. The argument is that predictive modelling reduces development risk and accelerates decisions, so candidates are refined and go or no-go calls made earlier, when they cost less. Simcyp applies physiologically based pharmacokinetic modelling to predict drug behaviour across diverse populations, which matters for dosing in groups rarely represented in trials. Phoenix handles pharmacokinetic, pharmacodynamic and toxicokinetic analysis and modelling. Early clinical work uses simulation for first-in-human success and precision dosing, and preclinical work uses predictive modelling and dosing optimisation to streamline IND submissions.

The regulatory and data tools address the submission itself. Pinnacle 21 covers data standardisation and validation against recognised standards, GlobalSubmit publishes, reviews and transmits eCTD submissions to health authorities, and CoAuthor applies generative AI, templates and structured content to regulatory writing. SEND Explorer visualises nonclinical data for trends and outliers. On the science side, D360 provides scientific informatics for accessing and visualising molecule and bioactivity data, Chemaxon supplies chemical and biological intelligence, and Certara IQ integrates biological and pharmacological insight to optimise efficacy and safety predictions. BaseCase builds interactive value stories for market access, and Certara.AI is the AI platform across the portfolio. A Non-Animal Navigator addresses the shift away from animal testing. Pricing is not published.

IQVIA is a global life sciences company operating in more than 100 countries, providing data, technology, and analytics solutions spanning clinical research, commercial strategy, real-world evidence, and regulatory compliance. Its offerings include clinical trial management suites, patient engagement tools, brand and oncology analytics platforms, and an Analytics Engine for self-service cohort analysis, all drawing on more than 64 petabytes of proprietary healthcare data and 1.2 billion or more non-identified patient records.

Recent additions include the IQVIA AI Platform and Agentic AI capabilities embedded across its solution suites, alongside its long-standing Global Pricing and Contracting practice, which advises life sciences clients on market access and pricing strategy. IQVIA does not publish product pricing; costs are quoted per solution, module, and client scope through its sales and account teams.